Research

For patients with glaucoma, the ability to detect any changes in their peripheral vision (visual field) is critical to their management...

Analysis of 120,000 records held on the UK Biobank, a large-scale population-based biomedical database, has shed light on the role of genetics and diet in glaucoma...

The TArgeting Metabolic INsufficiency in Glaucoma with nicotinamide (TAMING) trial is a world-first randomised-controlled clinical trial to be conducted in partnership with Glaucoma Australia and the Centre for Eye Research Australia...

Applications for the annual Glaucoma Australia ‘Quinlivan’ Research Grants are now open

Steroids come in a range of different formulations including topical drops and creams, inhaled, injectable and oral. Steroids, however, can increase intraocular pressure in some people...

Myopia (near-sightedness) is a significant risk factor for the development of glaucoma.1,2 There are a number of reasons for this, not all of which are well understood...

Researchers from the University of Birmingham in the UK are paving the way for promising new anti-fibrotic therapies to be developed for the treatment of open angle glaucoma...

Ten Australian institutions involving some of the country’s most prominent glaucoma researchers were involved in the international effort which analysed genes in more than 34,000 people with glaucoma across multiple ancestries for the first time...

Scientists at the University of Birmingham have successfully carried out experiments using soundwaves and an eye model and concluded that smartphones could be used to scan people’s eyes for early-warning signs of glaucoma...